In vivo enzyme activity of purified human brain renin.
Cerebrospinal fluid (CSF) of rats contains high angiotensinogen concentrations. When 3500-fold purified renin from human brain was injected into the brain ventricles of rats, angiotensin I concentrations increased from undetectable levels to 147.9 +/- 18.8 fMol per ml CSF. In parallel, mean arterial blood pressure increased from 93 +/- 2.4 mm Hg to 107 +/- 3.7 mm Hg. The increase in blood pressure could be abolished by intraventricular administration of saralasin, a blocker of angiotensin II receptors. Intraventricular injection of cathepsin D had no effect on arterial blood pressure and the agiotensin I concentration in CSF remained below detection limits of the radioimmunoassay. We conclude that brain renin acts on endogenous brain angiotensinogen under physioloical in vivo conditions to form angiotensin I. The latter is converted to angiotensin II and leads to biological effects, i.e. increase of blood pressure.
D000803:Angiotensin I / Q000096:biosynthesis; D000804:Angiotensin II / Q000502:physiology*; D000808:Angiotensinogen / Q000134:cerebrospinal fluid*; D000809:Angiotensins / Q000134:cerebrospinal fluid*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000201:enzymology*; D002403:Cathepsins / Q000494:pharmacology; D006801:Humans; D007276:Injections, Intraventricular; D008297:Male; D051381:Rats; D012083:Renin / Q000302:isolation & purification / Q000378:metabolism* / Q000502:physiology
D000809:Angiotensins; D000808:Angiotensinogen; D000804:Angiotensin II; D000803:Angiotensin I; D002403:Cathepsins; D012083:Renin